GLP-1 Receptor Agonist [EPC]

GLP-1 Receptor Agonist [EPC] was reported 448291 times

Drugs of the GLP-1 Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DRUG TITRATION ISSUE 116 0.6339
1 CYCLIC VOMITING SYNDROME 463 0.6325
2 MEDULLARY THYROID CANCER 175 0.5147
3 INJECTION SITE COLDNESS 423 0.4988
4 ACCIDENTAL UNDERDOSE 7074 0.4910
5 INTERCEPTED PRODUCT SELECTION ERROR 633 0.4862
6 GASTRIC HYPOMOTILITY 144 0.4691
7 IMPAIRED GASTRIC EMPTYING 6390 0.4683
8 EARLY SATIETY 837 0.4297
9 INTERCEPTED PRODUCT DISPENSING ERROR 640 0.3858
10 GASTROINTESTINAL HYPOMOTILITY 851 0.3772
11 THERAPEUTIC RESPONSE CHANGED 2271 0.3581
12 ERUCTATION 6904 0.3565
13 INJECTION SITE INJURY 1956 0.3524
14 OBSTRUCTIVE PANCREATITIS 263 0.3438
15 EXTRA DOSE ADMINISTERED 13865 0.3419
16 GLYCOSYLATED HAEMOGLOBIN DECREASED 482 0.2992
17 FOOD CRAVING 1569 0.2978
18 PULMONARY VASCULITIS 156 0.2900
19 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 342 0.2855
20 TOTAL LUNG CAPACITY ABNORMAL 111 0.2853
21 HUNGER 3897 0.2795
22 CORRECTIVE LENS USER 266 0.2731
23 OPTIC ISCHAEMIC NEUROPATHY 1055 0.2723
24 PRODUCT TAMPERING 483 0.2688
25 GLYCOSYLATED HAEMOGLOBIN INCREASED 6675 0.2642
26 SKIN LAXITY 106 0.2420
27 DRUG DOSE TITRATION NOT PERFORMED 438 0.2390
28 WEIGHT LOSS POOR 1197 0.2339
29 INJECTION SITE HYPERSENSITIVITY 728 0.2326
30 BLOOD GLUCOSE DECREASED 11145 0.2319
31 ADENOCARCINOMA PANCREAS 295 0.2296
32 PANCREATIC CARCINOMA METASTATIC 646 0.2269
33 ALLODYNIA 256 0.2190
34 ACCIDENTAL NEEDLE STICK 174 0.2101
35 THIRST DECREASED 123 0.1959
36 FOOD AVERSION 327 0.1925
37 BLOOD GLUCOSE INCREASED 36186 0.1919
38 PAPILLARY THYROID CANCER 320 0.1839
39 SPIROMETRY ABNORMAL 107 0.1789
40 INCORRECT DOSE ADMINISTERED 40780 0.1785
41 MITE ALLERGY 114 0.1740
42 INCREASED APPETITE 3255 0.1702
43 INJECTION SITE PARAESTHESIA 252 0.1641
44 PANCREATITIS 8523 0.1611
45 VOMITING PROJECTILE 463 0.1599
46 INTERCEPTED PRODUCT PRESCRIBING ERROR 211 0.1591
47 BLOOD GLUCOSE FLUCTUATION 1683 0.1534
48 PANCREATIC ENZYMES INCREASED 210 0.1433
49 BLOOD GLUCOSE ABNORMAL 2649 0.1433
50 DIABETIC RETINOPATHY 484 0.1424
51 INJECTION SITE HAEMORRHAGE 11139 0.1393
52 LIPASE INCREASED 1056 0.1377
53 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 100 0.1364
54 THYROID MASS 520 0.1354
55 MYCOTIC ALLERGY 115 0.1345
56 EUGLYCAEMIC DIABETIC KETOACIDOSIS 555 0.1343
57 PANCREATITIS NECROTISING 296 0.1287
58 PRODUCT STORAGE ISSUE 482 0.1271
59 DUST ALLERGY 123 0.1254
60 ACCIDENTAL OVERDOSE 4520 0.1234
61 PANCREATITIS CHRONIC 292 0.1232
62 DRUG TITRATION ERROR 308 0.1192
63 KETOSIS 129 0.1189
64 HYPOGLYCAEMIC UNCONSCIOUSNESS 229 0.1155
65 NEURITIS 173 0.1120
66 INJECTION SITE MASS 4111 0.1111
67 INCORRECT PRODUCT FORMULATION ADMINISTERED 98 0.1107
68 PANCREATITIS ACUTE 2463 0.1095
69 FEEDING DISORDER 2199 0.1083
70 DIABETIC METABOLIC DECOMPENSATION 150 0.1080
71 INJECTION SITE BRUISING 8542 0.1070
72 DIABETES MELLITUS INADEQUATE CONTROL 1877 0.1059
73 BILIARY COLIC 308 0.1058
74 INJECTION SITE URTICARIA 2589 0.1054
75 PANCREATIC MASS 112 0.1047
76 PRODUCT COMMUNICATION ISSUE 909 0.1029
77 GASTROINTESTINAL SOUNDS ABNORMAL 510 0.1028
78 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1877 0.1023
79 INJURY ASSOCIATED WITH DEVICE 2072 0.1016
80 INJECTION SITE RASH 3109 0.1012
81 GALLBLADDER INJURY 191 0.0979
82 INJECTION SITE DISCOMFORT 1031 0.0979
83 INJECTION SITE IRRITATION 1247 0.0979
84 AMYLASE INCREASED 360 0.0975
85 PANCREATIC CYST 185 0.0968
86 OFF LABEL USE OF DEVICE 129 0.0953
87 INJECTION SITE VESICLES 576 0.0951
88 NECK MASS 269 0.0950
89 INJECTION SITE HYPOAESTHESIA 133 0.0929
90 INJECTION SITE PAIN 28511 0.0929
91 ILEUS 1112 0.0894
92 WEIGHT DECREASED 24849 0.0889
93 PANCREATIC NEOPLASM 110 0.0889
94 INFREQUENT BOWEL MOVEMENTS 218 0.0874
95 WRONG PATIENT RECEIVED PRODUCT 255 0.0871
96 PANCREATIC CARCINOMA 2486 0.0860
97 COUNTERFEIT PRODUCT ADMINISTERED 111 0.0851
98 FLATULENCE 4790 0.0844
99 POSTMENOPAUSAL HAEMORRHAGE 220 0.0843
100 STOMACH DISCOMFORT 435 0.0841
101 INSULIN RESISTANCE 175 0.0840
102 INJECTION SITE INDENTATION 182 0.0839
103 PANCREATIC DISORDER 408 0.0827
104 INJECTION SITE PRURITUS 5526 0.0824
105 DECREASED APPETITE 19062 0.0820
106 DYSPEPSIA 7878 0.0800
107 CONJUNCTIVITIS ALLERGIC 118 0.0796
108 APPETITE DISORDER 523 0.0788
109 FLUID INTAKE REDUCED 382 0.0763
110 CONSTIPATION 16538 0.0758
111 THYROID NEOPLASM 209 0.0757
112 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 490 0.0754
113 RETINOPATHY 280 0.0750
114 NAUSEA 58700 0.0741
115 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 151 0.0740
116 DIABETIC KETOACIDOSIS 1777 0.0739
117 HYPERPHAGIA 295 0.0739
118 PRODUCT LABEL CONFUSION 428 0.0734
119 BREATH ODOUR 179 0.0734
120 KETOACIDOSIS 533 0.0712
121 BODY MASS INDEX INCREASED 96 0.0711
122 CHOLELITHIASIS 2320 0.0707
123 FEELING JITTERY 1344 0.0705
124 HICCUPS 575 0.0700
125 ILLNESS 7171 0.0695
126 INJECTION SITE ERYTHEMA 8607 0.0693
127 ANOREXIA 893 0.0692
128 ENERGY INCREASED 397 0.0672
129 CHOLECYSTITIS 792 0.0664
130 HYPOGLYCAEMIA 3132 0.0645
131 ABDOMINAL DISTENSION 6637 0.0635
132 REGURGITATION 218 0.0634
133 INJECTION SITE SCAR 179 0.0628
134 FOOD POISONING 336 0.0627
135 VOMITING 28701 0.0610
136 DIABETIC NEUROPATHY 298 0.0601
137 GOITRE 246 0.0600
138 RESPIRATORY SYMPTOM 169 0.0594
139 BILE DUCT STONE 188 0.0590
140 ABDOMINAL PAIN UPPER 12030 0.0584
141 BOWEL MOVEMENT IRREGULARITY 444 0.0579
142 CHOLECYSTITIS INFECTIVE 160 0.0576
143 GASTRIC DILATATION 96 0.0575
144 SENSITIVE SKIN 424 0.0574
145 WEIGHT FLUCTUATION 597 0.0570
146 GASTROOESOPHAGEAL REFLUX DISEASE 4566 0.0567
147 ABNORMAL LOSS OF WEIGHT 385 0.0564
148 INJECTION SITE NODULE 620 0.0563
149 CATARACT OPERATION 333 0.0561
150 INJECTION SITE DISCHARGE 301 0.0559
151 INTESTINAL OBSTRUCTION 2081 0.0552
152 THYROID CANCER 649 0.0539
153 INJECTION SITE EXTRAVASATION 661 0.0535
154 CHOLECYSTITIS ACUTE 302 0.0532
155 FAECES HARD 202 0.0519
156 INJECTION SITE INFLAMMATION 257 0.0515
157 RETCHING 1082 0.0507
158 MUSCLE ATROPHY 639 0.0504
159 GASTROINTESTINAL PAIN 543 0.0493
160 WRONG DOSE 119 0.0492
161 GASTROINTESTINAL DISORDER 4383 0.0489
162 PRODUCT DISPENSING ERROR 1056 0.0484
163 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8644 0.0479
164 WEIGHT INCREASED 10732 0.0479
165 DEHYDRATION 6384 0.0478
166 GASTROENTERITIS VIRAL 844 0.0467
167 COLITIS ISCHAEMIC 313 0.0463
168 TASTE DISORDER 940 0.0463
169 INJECTION SITE REACTION 3184 0.0462
170 BRAIN FOG 724 0.0461
171 HYPOPHAGIA 1165 0.0455
172 HYPERCHLORHYDRIA 267 0.0453
173 DIARRHOEA 29087 0.0450
174 ABDOMINAL DISCOMFORT 7517 0.0448
175 MALNUTRITION 493 0.0440
176 INJECTION SITE DISCOLOURATION 548 0.0438
177 PRODUCT DISPENSING ISSUE 187 0.0437
178 INJECTION SITE HAEMATOMA 629 0.0433
179 COLONOSCOPY 95 0.0431
180 FORCED EXPIRATORY VOLUME DECREASED 121 0.0427
181 NORMOCHROMIC NORMOCYTIC ANAEMIA 128 0.0426
182 INJECTION SITE SWELLING 3223 0.0420
183 APPENDICITIS 384 0.0411
184 GLOMERULAR FILTRATION RATE DECREASED 503 0.0409
185 VISUAL IMPAIRMENT 5044 0.0407
186 GALLBLADDER DISORDER 725 0.0406
187 PAROSMIA 306 0.0405
188 INTENTIONAL DEVICE MISUSE 177 0.0401
189 ABDOMINAL RIGIDITY 107 0.0394
190 ILEUS PARALYTIC 176 0.0394
191 DIABETIC FOOT 119 0.0388
192 CHOLECYSTECTOMY 434 0.0380
193 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 636 0.0374
194 SMALL INTESTINAL OBSTRUCTION 456 0.0370
195 THIRST 658 0.0368
196 ABDOMINAL PAIN 8535 0.0367
197 COLD SWEAT 646 0.0366
198 SLUGGISHNESS 363 0.0356
199 FEELING COLD 988 0.0355
200 DEPRESSION SUICIDAL 122 0.0352
201 INTERCEPTED PRODUCT STORAGE ERROR 125 0.0350
202 INJECTION SITE INFECTION 115 0.0350
203 HEPATIC STEATOSIS 647 0.0347
204 NEUROLOGICAL SYMPTOM 194 0.0339
205 OVERWEIGHT 182 0.0338
206 RENAL PAIN 359 0.0338
207 GASTRITIS 891 0.0338
208 LACTIC ACIDOSIS 1089 0.0336
209 FOOD INTOLERANCE 123 0.0336
210 JAUNDICE CHOLESTATIC 118 0.0334
211 NEAR DEATH EXPERIENCE 110 0.0333
212 PRODUCT DOSE OMISSION ISSUE 9719 0.0330
213 INJECTION SITE INDURATION 423 0.0326
214 SKIN ODOUR ABNORMAL 128 0.0325
215 SUSPECTED COUNTERFEIT PRODUCT 128 0.0323
216 DYSCHEZIA 98 0.0321
217 GASTROENTERITIS 465 0.0318
218 PHARYNGOLARYNGEAL PAIN 169 0.0318
219 FAECALOMA 174 0.0317
220 ARTERIOSCLEROSIS CORONARY ARTERY 210 0.0317
221 URINE ODOUR ABNORMAL 186 0.0316
222 GASTROINTESTINAL MOTILITY DISORDER 169 0.0315
223 FEAR OF INJECTION 225 0.0315
224 HYPOACUSIS 1319 0.0306
225 SPINAL STENOSIS 126 0.0305
226 UNDERDOSE 2223 0.0304
227 DEVICE OPERATIONAL ISSUE 131 0.0304
228 DEPRESSED MOOD 1602 0.0303
229 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 518 0.0302
230 SENSATION OF FOREIGN BODY 254 0.0301
231 BLINDNESS UNILATERAL 423 0.0300
232 DRUG EFFECT DECREASED 1612 0.0299
233 PRODUCT STORAGE ERROR 2616 0.0299
234 NEPHROGENIC ANAEMIA 137 0.0295
235 FUNCTIONAL GASTROINTESTINAL DISORDER 102 0.0295
236 HYPERGLYCAEMIA 1075 0.0295
237 RETINAL DETACHMENT 269 0.0292
238 INTESTINAL ISCHAEMIA 161 0.0292
239 CATARACT 1736 0.0291
240 AUTOIMMUNE THYROIDITIS 110 0.0291
241 CHOLANGITIS 179 0.0288
242 ANAL INCONTINENCE 259 0.0288
243 BLOOD TRIGLYCERIDES INCREASED 505 0.0286
244 PULMONARY ALVEOLAR HAEMORRHAGE 160 0.0285
245 INJECTION SITE WARMTH 586 0.0285
246 PRESYNCOPE 690 0.0284
247 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5732 0.0283
248 WRONG PRODUCT ADMINISTERED 191 0.0282
249 NEPHROLITHIASIS 1291 0.0281
250 ABDOMINAL TENDERNESS 139 0.0280
251 INCORRECT DOSE ADMINISTERED BY DEVICE 718 0.0274
252 DYSGEUSIA 2014 0.0271
253 POLLAKIURIA 1126 0.0270
254 VITREOUS FLOATERS 262 0.0266
255 EPIGASTRIC DISCOMFORT 104 0.0266
256 VISION BLURRED 3651 0.0266
257 SLEEP APNOEA SYNDROME 506 0.0265
258 RENAL FUNCTION TEST ABNORMAL 123 0.0265
259 EATING DISORDER 562 0.0264
260 FEELING ABNORMAL 6318 0.0263
261 HYPOVOLAEMIA 154 0.0263
262 ARTERIOSCLEROSIS 246 0.0261
263 FLANK PAIN 244 0.0260
264 MENISCUS INJURY 160 0.0260
265 TRIGGER FINGER 106 0.0259
266 DIVERTICULUM INTESTINAL 113 0.0258
267 EYE OPERATION 119 0.0258
268 NERVOUSNESS 1349 0.0258
269 ALOPECIA 5059 0.0257
270 OFF LABEL USE 22366 0.0255
271 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 156 0.0252
272 OROPHARYNGEAL DISCOMFORT 227 0.0251
273 VISUAL DISTURBANCE 144 0.0251
274 INTENTIONAL PRODUCT MISUSE 2196 0.0251
275 PHARYNGEAL SWELLING 244 0.0249
276 DIZZINESS POSTURAL 241 0.0248
277 URINE OUTPUT DECREASED 217 0.0248
278 DIZZINESS 12354 0.0247
279 NODULE 323 0.0247
280 VULVOVAGINAL MYCOTIC INFECTION 97 0.0246
281 EYE HAEMORRHAGE 329 0.0246
282 DIVERTICULITIS 679 0.0245
283 THYROID DISORDER 376 0.0244
284 PRODUCT PRESCRIBING ERROR 579 0.0243
285 DISABILITY 474 0.0239
286 INSURANCE ISSUE 366 0.0239
287 ABNORMAL FAECES 196 0.0239
288 FUNGAL INFECTION 796 0.0239
289 LETHARGY 1364 0.0237
290 CARDIAC FLUTTER 152 0.0235
291 BLOOD MAGNESIUM DECREASED 202 0.0234
292 PRODUCT ADMINISTRATION INTERRUPTED 183 0.0233
293 CORONARY ARTERY OCCLUSION 318 0.0232
294 SEASONAL ALLERGY 327 0.0231
295 VULVOVAGINAL PRURITUS 117 0.0231
296 RETINAL HAEMORRHAGE 164 0.0230
297 GALLBLADDER OPERATION 93 0.0230
298 MACULAR DEGENERATION 274 0.0229
299 UMBILICAL HERNIA 107 0.0229
300 HYPERHIDROSIS 2939 0.0228
301 BLOOD CHOLESTEROL ABNORMAL 105 0.0227
302 INTERMENSTRUAL BLEEDING 127 0.0227
303 RENAL CYST 179 0.0225
304 METASTASES TO LIVER 396 0.0225
305 BLINDNESS 917 0.0225
306 TREMOR 3714 0.0224
307 ABDOMINAL HERNIA 102 0.0223
308 HEART RATE INCREASED 2204 0.0222
309 RENAL DISORDER 1034 0.0222
310 DEVICE MECHANICAL ISSUE 302 0.0220
311 HEAVY MENSTRUAL BLEEDING 198 0.0220
312 GOUT 394 0.0219
313 DRY MOUTH 1770 0.0218
314 URINE ABNORMALITY 99 0.0218
315 MACULAR OEDEMA 121 0.0216
316 DEFAECATION URGENCY 151 0.0215
317 SPINAL OPERATION 265 0.0215
318 ACUTE KIDNEY INJURY 3285 0.0214
319 BLINDNESS TRANSIENT 158 0.0214
320 MUSCULOSKELETAL DISCOMFORT 367 0.0213
321 DEVICE MALFUNCTION 1497 0.0213
322 DRUG EFFECT LESS THAN EXPECTED 315 0.0212
323 MALAISE 9303 0.0212
324 CONCUSSION 164 0.0212
325 CARDIAC OPERATION 182 0.0212
326 OBSTRUCTIVE AIRWAYS DISORDER 235 0.0211
327 FREQUENT BOWEL MOVEMENTS 570 0.0211
328 MULTIPLE USE OF SINGLE-USE PRODUCT 118 0.0210
329 FULL BLOOD COUNT ABNORMAL 222 0.0210
330 LIMB INJURY 570 0.0210
331 ASTHENIA 7885 0.0209
332 VASCULITIS 244 0.0209
333 HIATUS HERNIA 271 0.0209
334 HEADACHE 13061 0.0208
335 KIDNEY INFECTION 406 0.0207
336 POLYURIA 169 0.0206
337 KNEE OPERATION 203 0.0206
338 BLOOD PRESSURE DECREASED 1359 0.0204
339 METASTASES TO LYMPH NODES 138 0.0204
340 POST-TRAUMATIC STRESS DISORDER 137 0.0204
341 HAEMOGLOBIN INCREASED 93 0.0204
342 HERNIA 394 0.0204
343 THERAPY CHANGE 200 0.0203
344 PARAESTHESIA ORAL 292 0.0202
345 ACCIDENT 241 0.0202
346 PERIPHERAL COLDNESS 277 0.0202
347 LYMPHOEDEMA 139 0.0201
348 DEVICE FAILURE 306 0.0201
349 TOE AMPUTATION 102 0.0201
350 ASTHENOPIA 110 0.0200
351 MASS 278 0.0199
352 POLYP 130 0.0198
353 CARPAL TUNNEL SYNDROME 277 0.0198
354 AGEUSIA 493 0.0197
355 BLOOD POTASSIUM DECREASED 594 0.0197
356 FAECES DISCOLOURED 426 0.0196
357 SCIATICA 312 0.0196
358 ROTATOR CUFF SYNDROME 251 0.0195
359 PANIC ATTACK 712 0.0195
360 PALPITATIONS 2286 0.0195
361 GLUCOSE TOLERANCE IMPAIRED 115 0.0194
362 BLOOD LACTIC ACID INCREASED 102 0.0193
363 IRRITABLE BOWEL SYNDROME 414 0.0193
364 EYE DISORDER 627 0.0191
365 NECK PAIN 1062 0.0190
366 PRODUCT USE IN UNAPPROVED INDICATION 4703 0.0190
367 MEDICATION ERROR 1054 0.0189
368 FATIGUE 14738 0.0189
369 BACK DISORDER 306 0.0188
370 BLOOD CALCIUM INCREASED 164 0.0187
371 METABOLIC ACIDOSIS 597 0.0187
372 DECREASED ACTIVITY 201 0.0186
373 DIVERTICULUM 131 0.0184
374 HEPATIC CIRRHOSIS 345 0.0183
375 INFLUENZA 2045 0.0183
376 HYPOAESTHESIA ORAL 276 0.0183
377 ANKLE FRACTURE 283 0.0183
378 JOINT INJURY 389 0.0182
379 DIARRHOEA HAEMORRHAGIC 169 0.0181
380 MUSCULOSKELETAL CHEST PAIN 279 0.0180
381 NERVE COMPRESSION 166 0.0180
382 STENT PLACEMENT 145 0.0180
383 NOCTURIA 218 0.0179
384 PERONEAL NERVE PALSY 102 0.0179
385 RENAL FAILURE CHRONIC 138 0.0179
386 KNEE ARTHROPLASTY 376 0.0178
387 HYPOTHYROIDISM 570 0.0178
388 DEVICE DEFECTIVE 309 0.0178
389 HYPERAESTHESIA 146 0.0178
390 HYPERSOMNIA 507 0.0177
391 LARGE INTESTINE POLYP 121 0.0175
392 HAEMATEMESIS 442 0.0174
393 LIQUID PRODUCT PHYSICAL ISSUE 127 0.0174
394 ARTHROPOD BITE 129 0.0174
395 CEREBRAL DISORDER 128 0.0173
396 PHOTOPSIA 109 0.0172
397 DYSPHONIA 1008 0.0172
398 MULTIPLE ALLERGIES 135 0.0172
399 ELECTROLYTE IMBALANCE 200 0.0172
400 POOR QUALITY SLEEP 368 0.0171
401 DEVICE LEAKAGE 740 0.0170
402 BLOOD PRESSURE ABNORMAL 339 0.0170
403 METABOLIC DISORDER 99 0.0170
404 EXTRASYSTOLES 119 0.0170
405 MUSCLE STRAIN 147 0.0170
406 FRUSTRATION TOLERANCE DECREASED 137 0.0169
407 FAECES SOFT 123 0.0169
408 OBESITY 269 0.0169
409 VERTIGO 1029 0.0169
410 SCRATCH 178 0.0169
411 INTENTIONAL DOSE OMISSION 481 0.0169
412 NERVE INJURY 187 0.0168
413 ABDOMINAL PAIN LOWER 423 0.0167
414 DISCOMFORT 1020 0.0167
415 BLOOD IRON DECREASED 198 0.0167
416 COVID-19 2925 0.0167
417 INCORRECT PRODUCT STORAGE 219 0.0166
418 HYPERLIPIDAEMIA 199 0.0166
419 GASTROINTESTINAL INFECTION 149 0.0166
420 PYELONEPHRITIS 144 0.0166
421 CHRONIC KIDNEY DISEASE 1261 0.0166
422 VIRAL INFECTION 552 0.0166
423 CHROMATURIA 374 0.0166
424 EAR DISCOMFORT 170 0.0165
425 EXPOSURE VIA SKIN CONTACT 429 0.0165
426 ARTERIAL OCCLUSIVE DISEASE 130 0.0165
427 VITAMIN D DEFICIENCY 161 0.0165
428 UPPER-AIRWAY COUGH SYNDROME 136 0.0165
429 LYMPHADENOPATHY 583 0.0165
430 MYASTHENIA GRAVIS 133 0.0165
431 BLOOD POTASSIUM INCREASED 267 0.0164
432 TYPE 1 DIABETES MELLITUS 99 0.0164
433 DRY THROAT 167 0.0164
434 GANGRENE 99 0.0164
435 GLAUCOMA 316 0.0164
436 RASH PRURITIC 889 0.0164
437 COLITIS 621 0.0164
438 SINUS HEADACHE 97 0.0163
439 ROAD TRAFFIC ACCIDENT 681 0.0163
440 FOOT FRACTURE 308 0.0162
441 BACK PAIN 3774 0.0162
442 FEELING OF BODY TEMPERATURE CHANGE 95 0.0162
443 SALIVARY HYPERSECRETION 162 0.0162
444 BACK INJURY 176 0.0162
445 BLOOD URINE PRESENT 307 0.0162
446 ANXIETY 4585 0.0161
447 MUSCLE SPASMS 2956 0.0161
448 LIP SWELLING 536 0.0161
449 SNEEZING 361 0.0161
450 LOCALISED INFECTION 389 0.0161
451 SURGERY 943 0.0161
452 CHILLS 1870 0.0159
453 HYPERTRIGLYCERIDAEMIA 93 0.0159
454 VENTRICULAR EXTRASYSTOLES 164 0.0158
455 BLOOD CHOLESTEROL INCREASED 736 0.0158
456 MEMORY IMPAIRMENT 2167 0.0158
457 NASOPHARYNGITIS 2902 0.0157
458 NEEDLE ISSUE 458 0.0157
459 SKIN MASS 105 0.0157
460 DRUG DOSE OMISSION 2597 0.0157
461 MENSTRUAL DISORDER 130 0.0157
462 OCULAR DISCOMFORT 176 0.0157
463 DRUG INTOLERANCE 1504 0.0156
464 SUPRAVENTRICULAR TACHYCARDIA 149 0.0155
465 SYNCOPE 1555 0.0155
466 ASPIRATION 170 0.0155
467 PRODUCT DOSE OMISSION 1011 0.0155
468 HEAD DISCOMFORT 274 0.0155
469 WALKING AID USER 102 0.0155
470 BLOOD PRESSURE INCREASED 2362 0.0154
471 ARTHRITIS 1215 0.0154
472 ACIDOSIS 118 0.0154
473 NEPHROPATHY 144 0.0154
474 MIGRAINE 1471 0.0154
475 DEPRESSION 3492 0.0153
476 LOSS OF CONSCIOUSNESS 1965 0.0153
477 UTERINE LEIOMYOMA 112 0.0153
478 RENAL FAILURE 2029 0.0153
479 THERAPEUTIC RESPONSE UNEXPECTED 684 0.0152
480 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 712 0.0152
481 FEELING HOT 934 0.0152
482 INTERVERTEBRAL DISC PROTRUSION 332 0.0152
483 SKIN LACERATION 165 0.0152
484 URINARY TRACT INFECTION 2579 0.0151
485 HYPERTHYROIDISM 218 0.0150
486 URTICARIA 2510 0.0150
487 APHONIA 209 0.0150
488 HAEMORRHOIDS 292 0.0150
489 LIGAMENT SPRAIN 148 0.0150
490 COLON CANCER 223 0.0149
491 PANIC REACTION 108 0.0149
492 DIABETES MELLITUS 1138 0.0149
493 SUNBURN 111 0.0149
494 NEURALGIA 361 0.0148
495 PAIN OF SKIN 399 0.0148
496 MATERNAL EXPOSURE DURING PREGNANCY 1320 0.0148
497 TENDERNESS 154 0.0148
498 LIMB DISCOMFORT 456 0.0147
499 BIPOLAR DISORDER 160 0.0147
500 SKIN REACTION 207 0.0147
501 POST PROCEDURAL INFECTION 119 0.0146
502 HYPERSENSITIVITY 2697 0.0145
503 SUICIDAL IDEATION 1328 0.0145
504 SINUS DISORDER 287 0.0145
505 CHOLECYSTITIS CHRONIC 97 0.0145
506 IRON DEFICIENCY ANAEMIA 133 0.0144
507 ATRIAL FIBRILLATION 1401 0.0144
508 SINUS CONGESTION 194 0.0143
509 DYSURIA 526 0.0143
510 EMOTIONAL DISTRESS 1725 0.0142
511 INITIAL INSOMNIA 146 0.0142
512 BODY HEIGHT DECREASED 152 0.0142
513 OESOPHAGITIS 155 0.0142
514 BLOOD TESTOSTERONE DECREASED 97 0.0142
515 PRURITUS GENERALISED 306 0.0141
516 ORTHOSTATIC HYPOTENSION 246 0.0141
517 MICTURITION URGENCY 161 0.0141
518 HYSTERECTOMY 122 0.0141
519 RENAL IMPAIRMENT 1180 0.0140
520 OPTIC NEURITIS 127 0.0140
521 PEMPHIGOID 105 0.0139
522 IMPAIRED QUALITY OF LIFE 199 0.0138
523 HEAD INJURY 438 0.0138
524 THROAT IRRITATION 621 0.0138
525 INFLUENZA LIKE ILLNESS 1130 0.0137
526 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 659 0.0137
527 END STAGE RENAL DISEASE 250 0.0137
528 GASTROINTESTINAL INFLAMMATION 107 0.0136
529 HYPERKALAEMIA 479 0.0136
530 BURNING SENSATION 954 0.0136
531 CYSTITIS 432 0.0136
532 LOW DENSITY LIPOPROTEIN INCREASED 105 0.0136
533 CYST 168 0.0135
534 PRODUCT USE COMPLAINT 212 0.0134
535 PRODUCT DOSE OMISSION IN ERROR 381 0.0134
536 ATRIOVENTRICULAR BLOCK 104 0.0134
537 FACIAL PAIN 120 0.0134
538 CONTUSION 1289 0.0134
539 THROAT TIGHTNESS 362 0.0134
540 GAIT INABILITY 447 0.0134
541 TRANSIENT ISCHAEMIC ATTACK 451 0.0134
542 INSOMNIA 3555 0.0133
543 DRUG INEFFECTIVE 17587 0.0133
544 MOOD ALTERED 363 0.0133
545 HAND FRACTURE 94 0.0133
546 BLOOD THYROID STIMULATING HORMONE INCREASED 122 0.0132
547 SOMNOLENCE 2668 0.0132
548 JAUNDICE 356 0.0132
549 MOBILITY DECREASED 950 0.0132
550 UPPER LIMB FRACTURE 263 0.0132
551 NEUROPATHY PERIPHERAL 1246 0.0131
552 DEMENTIA 366 0.0131
553 FOOD ALLERGY 101 0.0131
554 CELLULITIS 659 0.0131
555 SINUSITIS 1333 0.0130
556 CARDIAC DISORDER 1214 0.0130
557 MYALGIA 2204 0.0130
558 FLUID RETENTION 659 0.0129
559 BLOOD CREATININE INCREASED 838 0.0128
560 APATHY 187 0.0128
561 SWOLLEN TONGUE 400 0.0128
562 CHEST PAIN 2364 0.0128
563 ERECTILE DYSFUNCTION 327 0.0127
564 OSTEOARTHRITIS 538 0.0127
565 HOT FLUSH 955 0.0127
566 PRODUCT USE ISSUE 2381 0.0127
567 PHARYNGITIS STREPTOCOCCAL 137 0.0126
568 IRRITABILITY 761 0.0126
569 AUTOIMMUNE DISORDER 123 0.0126
570 HEPATOMEGALY 124 0.0126
571 EAR INFECTION 335 0.0126
572 FALL 4188 0.0126
573 INTERVERTEBRAL DISC DEGENERATION 116 0.0125
574 SCAR 214 0.0125
575 PULMONARY MASS 186 0.0125
576 RHINORRHOEA 807 0.0125
577 EXOSTOSIS 114 0.0125
578 DERMATITIS ALLERGIC 157 0.0125
579 NEOPLASM 143 0.0124
580 DRUG DISPENSING ERROR 190 0.0124
581 THINKING ABNORMAL 231 0.0124
582 MIDDLE INSOMNIA 231 0.0124
583 EXPIRED PRODUCT ADMINISTERED 411 0.0124
584 DIPLOPIA 320 0.0123
585 VITAMIN D DECREASED 105 0.0123
586 TYPE 2 DIABETES MELLITUS 413 0.0123
587 PULMONARY FIBROSIS 235 0.0122
588 PRURITUS 4705 0.0122
589 HIP ARTHROPLASTY 187 0.0122
590 OROPHARYNGEAL PAIN 1124 0.0121
591 SKIN SWELLING 105 0.0121
592 SPINAL OSTEOARTHRITIS 106 0.0121
593 NASAL CONGESTION 709 0.0121
594 PERIPHERAL SWELLING 1858 0.0120
595 HEPATIC ENZYME INCREASED 813 0.0119
596 INCONTINENCE 126 0.0119
597 PHOTOPHOBIA 224 0.0119
598 BREAST PAIN 127 0.0119
599 RENAL FAILURE ACUTE 505 0.0119
600 DYSSTASIA 347 0.0119
601 EYE INFECTION 134 0.0119
602 LIVER FUNCTION TEST INCREASED 254 0.0118
603 INFUSION SITE PAIN 152 0.0118
604 DRUG INTERACTION 1868 0.0118
605 EYE PAIN 663 0.0117
606 FACIAL PARALYSIS 100 0.0117
607 ANAPHYLACTIC REACTION 648 0.0117
608 SLEEP DISORDER 827 0.0117
609 PAIN IN EXTREMITY 3443 0.0117
610 INABILITY TO AFFORD MEDICATION 116 0.0117
611 CEREBROVASCULAR ACCIDENT 1975 0.0116
612 DYSPHAGIA 1106 0.0116
613 VISUAL ACUITY REDUCED 386 0.0116
614 GROIN PAIN 102 0.0116
615 RECTAL HAEMORRHAGE 496 0.0115
616 HYPOAESTHESIA 1728 0.0115
617 SWELLING 1080 0.0115
618 COUGH 3232 0.0115
619 FIBROMYALGIA 280 0.0115
620 HAEMATOCHEZIA 634 0.0115
621 BLADDER DISORDER 114 0.0115
622 DEVICE DELIVERY SYSTEM ISSUE 313 0.0114
623 MUSCLE TIGHTNESS 185 0.0114
624 PARAESTHESIA 1792 0.0114
625 SKIN ULCER 294 0.0114
626 GASTRIC ULCER 216 0.0114
627 LIVER FUNCTION TEST ABNORMAL 330 0.0113
628 BLOOD UREA INCREASED 190 0.0113
629 GASTRIC DISORDER 389 0.0113
630 BRONCHITIS 839 0.0113
631 BRAIN NEOPLASM 104 0.0113
632 NEOPLASM MALIGNANT 753 0.0113
633 ASTHMA 1274 0.0113
634 ANGIOEDEMA 498 0.0112
635 LOWER LIMB FRACTURE 216 0.0112
636 MENTAL IMPAIRMENT 272 0.0112
637 CHEST DISCOMFORT 1146 0.0112
638 TINNITUS 514 0.0112
639 EYE SWELLING 416 0.0112
640 DRY EYE 558 0.0112
641 POST PROCEDURAL COMPLICATION 214 0.0111
642 DERMATITIS CONTACT 127 0.0111
643 PRODUCTIVE COUGH 531 0.0111
644 OSTEOMYELITIS 201 0.0111
645 METASTASES TO LUNG 128 0.0111
646 TOOTH INFECTION 146 0.0111
647 URINARY INCONTINENCE 328 0.0111
648 MUSCULAR WEAKNESS 1258 0.0111
649 HEPATITIS 283 0.0110
650 TOOTHACHE 200 0.0110
651 ANURIA 95 0.0110
652 PROCEDURAL PAIN 306 0.0110
653 RECALLED PRODUCT ADMINISTERED 105 0.0110
654 BALANCE DISORDER 950 0.0110
655 SPINAL DISORDER 104 0.0110
656 TOOTH FRACTURE 121 0.0110
657 HYPERTENSION 2321 0.0109
658 ADVERSE DRUG REACTION 983 0.0109
659 TENDON RUPTURE 135 0.0109
660 BLOOD SODIUM DECREASED 206 0.0109
661 MENSTRUATION DELAYED 118 0.0109
662 CORONARY ARTERY DISEASE 329 0.0109
663 VAGINAL HAEMORRHAGE 470 0.0108
664 LACRIMATION INCREASED 327 0.0108
665 DISORIENTATION 428 0.0108
666 OVERDOSE 2326 0.0108
667 HYPOKALAEMIA 496 0.0107
668 RENAL INJURY 319 0.0107
669 TACHYCARDIA 954 0.0107
670 RASH 4671 0.0107
671 HEART RATE IRREGULAR 241 0.0107
672 NIGHT SWEATS 343 0.0106
673 DEVICE ISSUE 952 0.0106
674 SWELLING FACE 691 0.0106
675 RIB FRACTURE 218 0.0106
676 ACCIDENTAL EXPOSURE TO PRODUCT 1091 0.0106
677 HIDRADENITIS 96 0.0105
678 UNEVALUABLE EVENT 795 0.0105
679 RESTLESS LEGS SYNDROME 191 0.0105
680 MENTAL DISORDER 457 0.0105
681 RENAL TUBULAR NECROSIS 103 0.0105
682 RASH GENERALISED 271 0.0105
683 INTESTINAL PERFORATION 117 0.0104
684 PRODUCT PACKAGING ISSUE 99 0.0104
685 ARTHRALGIA 4320 0.0104
686 PAIN 6382 0.0104
687 ULCER 165 0.0104
688 ACUTE MYOCARDIAL INFARCTION 305 0.0103
689 COVID-19 PNEUMONIA 122 0.0103
690 SPLENOMEGALY 121 0.0103
691 PRODUCT ODOUR ABNORMAL 108 0.0103
692 BURSITIS 125 0.0103
693 EAR PAIN 199 0.0102
694 DEVICE USE ISSUE 179 0.0102
695 TOOTH ABSCESS 104 0.0102
696 WRIST FRACTURE 122 0.0102
697 PRODUCT DISTRIBUTION ISSUE 94 0.0101
698 THERAPEUTIC RESPONSE SHORTENED 335 0.0101
699 MYOCARDIAL INFARCTION 1761 0.0101
700 ATELECTASIS 97 0.0100
701 TUBULOINTERSTITIAL NEPHRITIS 188 0.0100
702 SKIN HAEMORRHAGE 148 0.0100
703 ABORTION SPONTANEOUS 399 0.0099
704 GAIT DISTURBANCE 1904 0.0099
705 UPPER RESPIRATORY TRACT INFECTION 458 0.0099
706 DISTURBANCE IN ATTENTION 534 0.0099
707 HYPERCALCAEMIA 122 0.0099
708 BRAIN INJURY 99 0.0099
709 HYPOTENSION 1980 0.0099
710 LIVER DISORDER 436 0.0098
711 SKIN DISCOLOURATION 451 0.0098
712 ORAL DISCOMFORT 136 0.0098
713 ANAPHYLACTIC SHOCK 252 0.0098
714 ARRHYTHMIA 461 0.0097
715 SUDDEN DEATH 103 0.0097
716 ANGINA PECTORIS 278 0.0097
717 THERAPY CESSATION 498 0.0097
718 PHOTOSENSITIVITY REACTION 160 0.0097
719 HERPES ZOSTER 555 0.0096
720 ARTHROPATHY 536 0.0096
721 ALANINE AMINOTRANSFERASE INCREASED 591 0.0096
722 SEPSIS 1072 0.0096
723 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 682 0.0096
724 CONFUSIONAL STATE 1547 0.0096
725 JOINT DISLOCATION 101 0.0095
726 CHOKING 186 0.0095
727 LYMPHOMA 147 0.0095
728 INFLAMMATION 489 0.0095
729 GENERALISED OEDEMA 117 0.0094
730 DEAFNESS 247 0.0094
731 AMNESIA 611 0.0094
732 PRODUCT QUALITY ISSUE 1272 0.0094
733 CARDIAC FAILURE CONGESTIVE 752 0.0094
734 HAEMOPTYSIS 261 0.0093
735 CONDITION AGGRAVATED 2845 0.0093
736 URINARY RETENTION 312 0.0093
737 DYSPNOEA EXERTIONAL 351 0.0093
738 PARALYSIS 133 0.0093
739 THROMBOSIS 747 0.0093
740 DRUG PRESCRIBING ERROR 178 0.0093
741 PULMONARY CONGESTION 122 0.0092
742 DYSPNOEA 5200 0.0092
743 HYPOKINESIA 133 0.0092
744 HEART RATE DECREASED 321 0.0091
745 SPINAL FRACTURE 182 0.0091
746 BLOOD PRESSURE FLUCTUATION 218 0.0091
747 EYE PRURITUS 304 0.0090
748 ORAL CANDIDIASIS 119 0.0090
749 THERAPEUTIC PRODUCT EFFECT DECREASED 404 0.0090
750 PALLOR 245 0.0090
751 MULTIPLE ORGAN DYSFUNCTION SYNDROME 255 0.0090
752 LUNG DISORDER 441 0.0090
753 GAMMA-GLUTAMYLTRANSFERASE INCREASED 199 0.0090
754 WHITE BLOOD CELL COUNT INCREASED 343 0.0089
755 DEVICE DIFFICULT TO USE 590 0.0089
756 SPEECH DISORDER 464 0.0088
757 RESPIRATORY TRACT CONGESTION 140 0.0088
758 WHEEZING 521 0.0088
759 OEDEMA PERIPHERAL 1069 0.0088
760 DRUG DOSE OMISSION BY DEVICE 680 0.0087
761 DENTAL CARIES 96 0.0087
762 HYPOXIA 305 0.0087
763 PULMONARY EMBOLISM 823 0.0087
764 PSORIATIC ARTHROPATHY 351 0.0086
765 IMPAIRED WORK ABILITY 184 0.0086
766 LIVER INJURY 211 0.0086
767 ADRENAL INSUFFICIENCY 104 0.0086
768 MOOD SWINGS 272 0.0085
769 ORAL PAIN 191 0.0085
770 TENDONITIS 132 0.0085
771 WOUND 238 0.0085
772 FEAR 228 0.0085
773 SKIN INFECTION 95 0.0085
774 MYOCARDIAL ISCHAEMIA 96 0.0084
775 ACUTE RESPIRATORY FAILURE 161 0.0084
776 SPINAL PAIN 98 0.0084
777 BACTERIAL INFECTION 156 0.0084
778 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 433 0.0083
779 TOOTH EXTRACTION 103 0.0083
780 BEDRIDDEN 108 0.0082
781 MUSCLE TWITCHING 189 0.0082
782 PRODUCT AVAILABILITY ISSUE 186 0.0082
783 PAIN IN JAW 231 0.0081
784 HAIR TEXTURE ABNORMAL 109 0.0081
785 DIALYSIS 115 0.0081
786 EYE IRRITATION 466 0.0081
787 SHOCK 186 0.0081
788 SKIN FISSURES 158 0.0081
789 ANGER 273 0.0081
790 SECRETION DISCHARGE 101 0.0081
791 LEUKOCYTOSIS 145 0.0080
792 DRUG-INDUCED LIVER INJURY 250 0.0080
793 NIGHTMARE 275 0.0079
794 ILL-DEFINED DISORDER 481 0.0079
795 RESPIRATORY TRACT INFECTION 206 0.0079
796 FLUSHING 804 0.0079
797 OCULAR HYPERAEMIA 375 0.0079
798 ANOSMIA 114 0.0079
799 PRODUCT ADMINISTRATION ERROR 159 0.0079
800 RASH ERYTHEMATOUS 376 0.0079
801 CEREBRAL INFARCTION 192 0.0079
802 INTENTIONAL PRODUCT USE ISSUE 688 0.0078
803 ASPARTATE AMINOTRANSFERASE INCREASED 417 0.0078
804 CRYING 285 0.0078
805 HYPOMAGNESAEMIA 109 0.0078
806 INTRAOCULAR PRESSURE INCREASED 100 0.0078
807 IMMUNE SYSTEM DISORDER 103 0.0078
808 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 427 0.0078
809 HEPATIC CYTOLYSIS 99 0.0078
810 ECZEMA 406 0.0078
811 CANDIDA INFECTION 131 0.0077
812 ISCHAEMIC STROKE 138 0.0077
813 PROTEINURIA 147 0.0077
814 THERAPY INTERRUPTED 552 0.0077
815 MUSCULOSKELETAL STIFFNESS 673 0.0077
816 PNEUMONIA ASPIRATION 191 0.0076
817 RASH MACULAR 267 0.0076
818 BLOOD ALKALINE PHOSPHATASE INCREASED 189 0.0076
819 BLISTER 425 0.0076
820 HOSPITALISATION 1161 0.0075
821 PROSTATIC SPECIFIC ANTIGEN INCREASED 104 0.0075
822 BLOOD PRESSURE SYSTOLIC INCREASED 147 0.0075
823 NO ADVERSE EVENT 1365 0.0075
824 DEEP VEIN THROMBOSIS 486 0.0075
825 BLOOD TEST ABNORMAL 105 0.0075
826 ABSCESS 119 0.0075
827 OEDEMA 404 0.0074
828 MUSCULOSKELETAL PAIN 390 0.0074
829 JOINT STIFFNESS 195 0.0074
830 RESPIRATORY DISORDER 222 0.0074
831 OXYGEN SATURATION DECREASED 414 0.0074
832 SINUS TACHYCARDIA 104 0.0073
833 CHOLESTASIS 140 0.0073
834 CARDIAC FAILURE 584 0.0073
835 RASH PAPULAR 162 0.0072
836 STAPHYLOCOCCAL INFECTION 238 0.0072
837 EPISTAXIS 533 0.0071
838 DYSARTHRIA 268 0.0071
839 ABNORMAL DREAMS 196 0.0071
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 500 0.0070
841 PRODUCT PRESCRIBING ISSUE 153 0.0070
842 QUALITY OF LIFE DECREASED 94 0.0070
843 THERAPY NON-RESPONDER 314 0.0070
844 PHARYNGEAL OEDEMA 107 0.0069
845 SEPTIC SHOCK 300 0.0069
846 SKIN EXFOLIATION 581 0.0069
847 DRUG ADMINISTRATION ERROR 211 0.0069
848 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 232 0.0069
849 SKIN DISORDER 229 0.0069
850 RESTLESSNESS 251 0.0069
851 BREAST CANCER 637 0.0068
852 RHABDOMYOLYSIS 284 0.0068
853 DERMATITIS ATOPIC 357 0.0068
854 HIP FRACTURE 217 0.0067
855 CLOSTRIDIUM DIFFICILE INFECTION 147 0.0067
856 COGNITIVE DISORDER 313 0.0067
857 INFECTION 964 0.0067
858 ORAL HERPES 130 0.0067
859 IMPAIRED HEALING 217 0.0066
860 COLITIS ULCERATIVE 295 0.0066
861 INTERNATIONAL NORMALISED RATIO INCREASED 188 0.0066
862 CARDIOMYOPATHY 97 0.0066
863 BONE DISORDER 119 0.0065
864 TOOTH DISORDER 145 0.0065
865 DRY SKIN 865 0.0065
866 BONE PAIN 379 0.0065
867 APHASIA 195 0.0065
868 ANHEDONIA 169 0.0064
869 MUSCULOSKELETAL DISORDER 122 0.0064
870 PERICARDIAL EFFUSION 148 0.0064
871 SKIN BURNING SENSATION 458 0.0064
872 CONTRAINDICATED PRODUCT ADMINISTERED 193 0.0064
873 ERYTHEMA 1305 0.0063
874 CIRCULATORY COLLAPSE 108 0.0063
875 BLOOD BILIRUBIN INCREASED 171 0.0063
876 INCORRECT PRODUCT ADMINISTRATION DURATION 137 0.0063
877 PYREXIA 2188 0.0063
878 EJECTION FRACTION DECREASED 98 0.0063
879 JOINT SWELLING 760 0.0063
880 SEIZURE 721 0.0062
881 HAEMATURIA 213 0.0062
882 AMENORRHOEA 109 0.0062
883 PARANOIA 107 0.0062
884 BODY TEMPERATURE INCREASED 126 0.0062
885 PNEUMONIA 1996 0.0062
886 PULMONARY OEDEMA 276 0.0062
887 CARDIOVASCULAR DISORDER 156 0.0061
888 VENTRICULAR TACHYCARDIA 101 0.0061
889 PSORIASIS 797 0.0061
890 BASAL CELL CARCINOMA 95 0.0061
891 TREATMENT NONCOMPLIANCE 332 0.0061
892 PRODUCT PREPARATION ERROR 124 0.0060
893 ASCITES 177 0.0060
894 SKIN LESION 162 0.0059
895 BLADDER CANCER 347 0.0059
896 HYPONATRAEMIA 328 0.0058
897 COMA 276 0.0058
898 HAEMORRHAGE 604 0.0058
899 ALTERED STATE OF CONSCIOUSNESS 125 0.0058
900 FRACTURE 109 0.0058
901 DEVICE USE ERROR 200 0.0057
902 DRUG LEVEL INCREASED 94 0.0057
903 UPPER GASTROINTESTINAL HAEMORRHAGE 95 0.0056
904 CEREBRAL HAEMORRHAGE 202 0.0056
905 MENSTRUATION IRREGULAR 151 0.0056
906 SKIN CANCER 121 0.0056
907 CARDIAC ARREST 463 0.0056
908 FACE OEDEMA 94 0.0056
909 DEVICE BREAKAGE 226 0.0056
910 EMOTIONAL DISORDER 171 0.0055
911 SKIN IRRITATION 254 0.0055
912 THERAPEUTIC RESPONSE DECREASED 336 0.0055
913 HEPATIC FAILURE 167 0.0055
914 PULMONARY HYPERTENSION 115 0.0055
915 LOWER RESPIRATORY TRACT INFECTION 248 0.0054
916 DERMATITIS 114 0.0054
917 PRESCRIBED OVERDOSE 105 0.0054
918 LABORATORY TEST ABNORMAL 160 0.0054
919 OSTEOPOROSIS 223 0.0054
920 GENERAL PHYSICAL HEALTH DETERIORATION 627 0.0054
921 AGITATION 390 0.0053
922 C-REACTIVE PROTEIN INCREASED 193 0.0053
923 NERVOUS SYSTEM DISORDER 163 0.0052
924 ANAEMIA 995 0.0052
925 BLOOD CREATINE PHOSPHOKINASE INCREASED 150 0.0052
926 HEPATIC CANCER 125 0.0052
927 HAEMATOMA 133 0.0051
928 GASTROINTESTINAL HAEMORRHAGE 429 0.0051
929 INJURY 358 0.0051
930 GLOSSODYNIA 114 0.0051
931 TRANSAMINASES INCREASED 112 0.0050
932 HYPOCALCAEMIA 95 0.0050
933 MELAENA 110 0.0050
934 MOVEMENT DISORDER 160 0.0050
935 MOUTH ULCERATION 102 0.0048
936 PSYCHOTIC DISORDER 142 0.0048
937 LUNG NEOPLASM MALIGNANT 196 0.0048
938 PRODUCT PHYSICAL ISSUE 96 0.0048
939 RHEUMATOID ARTHRITIS 538 0.0047
940 TOOTH LOSS 96 0.0046
941 SYSTEMIC LUPUS ERYTHEMATOSUS 164 0.0046
942 HEPATIC FUNCTION ABNORMAL 172 0.0046
943 DYSKINESIA 185 0.0045
944 PLEURAL EFFUSION 274 0.0045
945 ENCEPHALOPATHY 110 0.0045
946 HALLUCINATION 333 0.0044
947 RED BLOOD CELL COUNT DECREASED 126 0.0044
948 DELIRIUM 151 0.0043
949 TREATMENT FAILURE 343 0.0041
950 STOMATITIS 250 0.0041
951 RESPIRATORY FAILURE 300 0.0041
952 MENTAL STATUS CHANGES 114 0.0041
953 FEMUR FRACTURE 127 0.0041
954 DISEASE RECURRENCE 193 0.0041
955 DEPRESSED LEVEL OF CONSCIOUSNESS 159 0.0040
956 ADVERSE EVENT 365 0.0040
957 ABNORMAL BEHAVIOUR 156 0.0039
958 HAEMOGLOBIN DECREASED 399 0.0039
959 MULTIPLE SCLEROSIS 185 0.0039
960 EPILEPSY 117 0.0038
961 SUICIDE ATTEMPT 230 0.0038
962 GASTRIC CANCER 96 0.0038
963 PHARMACEUTICAL PRODUCT COMPLAINT 98 0.0038
964 CARDIO-RESPIRATORY ARREST 156 0.0037
965 BRADYCARDIA 194 0.0037
966 RENAL CANCER 160 0.0034
967 ACNE 254 0.0033
968 PRODUCT SUBSTITUTION ISSUE 187 0.0032
969 PLATELET COUNT DECREASED 341 0.0032
970 INTENTIONAL OVERDOSE 200 0.0031
971 WRONG TECHNIQUE IN DRUG USAGE PROCESS 113 0.0031
972 AGGRESSION 155 0.0031
973 WITHDRAWAL SYNDROME 130 0.0031
974 INTERSTITIAL LUNG DISEASE 142 0.0029
975 DEATH 2484 0.0029
976 INFUSION RELATED REACTION 182 0.0027
977 PROSTATE CANCER 219 0.0027
978 WHITE BLOOD CELL COUNT DECREASED 274 0.0025
979 FOETAL EXPOSURE DURING PREGNANCY 202 0.0025
980 THROMBOCYTOPENIA 263 0.0023
981 EXPOSURE DURING PREGNANCY 146 0.0023
982 PANCYTOPENIA 116 0.0021
983 TOXICITY TO VARIOUS AGENTS 290 0.0017
984 MULTIPLE SCLEROSIS RELAPSE 115 0.0017
985 NEUTROPENIA 203 0.0015
986 COMPLETED SUICIDE 120 0.0014
987 DRUG WITHDRAWAL SYNDROME 117 0.0013
988 DISEASE PROGRESSION 142 0.0012
989 MALIGNANT NEOPLASM PROGRESSION 109 0.0011
990 DRUG DEPENDENCE 103 0.0006